Pre-Operative Direct Oral Anticoagulant Level Measurement Reduces Time to Surgery in Hip Fracture Patients.

IF 1.6 4区 医学 Q4 GERIATRICS & GERONTOLOGY
Geriatric Orthopaedic Surgery & Rehabilitation Pub Date : 2024-12-09 eCollection Date: 2024-01-01 DOI:10.1177/21514593221142187
Stephanie Su-Yin P'ng, Yue Wern Teh, Sophie Reynolds, Glenn Boardman, Christopher W Jones, Hannah Seymour
{"title":"Pre-Operative Direct Oral Anticoagulant Level Measurement Reduces Time to Surgery in Hip Fracture Patients.","authors":"Stephanie Su-Yin P'ng, Yue Wern Teh, Sophie Reynolds, Glenn Boardman, Christopher W Jones, Hannah Seymour","doi":"10.1177/21514593221142187","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>The optimal management of patients taking DOAC medications in the perioperative trauma setting is based on limited evidence. Current guidelines recommend withholding DOAC medications 48-72 hours pre-operatively. The objective of this trial was to determine the utility of measuring DOAC levels prior to surgery, evaluate the safety of a cut-off level of <50 ng/mL and to compare the outcomes with time parameters.</p><p><strong>Materials and methods: </strong>We performed a cohort study of patients aged 50 years and older admitted with a hip fracture who underwent surgery between January 12 017 and December 31 2019. Primary outcome was time to surgery (TTS) in hours. Secondary outcomes include inpatient transfusion and thromboembolism rates and 30-day mortality.</p><p><strong>Results: </strong>1579 patients underwent operative management of their hip fracture. The mean TTS in the DOAC group was 33.0 hours. This was significantly longer when compared to patients not on anticoagulation whose mean TTS was 24.4hours (95% CI -13.78: -8.71, <i>P</i> value <.05). It was also significantly higher than patients on warfarin whose mean TTS was 26.4hours (95% CI -12.41: -4.18, <i>P</i> value <.05). There was no significant difference in the transfusion rate and 30-day mortality between the groups (X<sup>2</sup> = 2.086, df = 2, <i>P</i> value = .352)]. There was no significant difference in transfusion rates and 30-day mortality between the patients with a DOAC level <50 ng/mL compared with the patients not on any anticoagulation. There was no significant difference in 30-day mortality or transfusion rates between those patients on a DOAC operated within 48 hours compared with those operated after 48 hours (<i>P</i> value = .67).</p><p><strong>Discussion and conclusion: </strong>DOAC therapy delays surgery for patients with a hip fracture. Using a DOAC level <50 ng/mL is a safe level to proceed with surgery and reduces the TTS compared to following current guidelines. If DOAC levels are not available the data still supports operation at 48 hours.</p>","PeriodicalId":48568,"journal":{"name":"Geriatric Orthopaedic Surgery & Rehabilitation","volume":"15 ","pages":"21514593221142187"},"PeriodicalIF":1.6000,"publicationDate":"2024-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11629414/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Geriatric Orthopaedic Surgery & Rehabilitation","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/21514593221142187","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"GERIATRICS & GERONTOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: The optimal management of patients taking DOAC medications in the perioperative trauma setting is based on limited evidence. Current guidelines recommend withholding DOAC medications 48-72 hours pre-operatively. The objective of this trial was to determine the utility of measuring DOAC levels prior to surgery, evaluate the safety of a cut-off level of <50 ng/mL and to compare the outcomes with time parameters.

Materials and methods: We performed a cohort study of patients aged 50 years and older admitted with a hip fracture who underwent surgery between January 12 017 and December 31 2019. Primary outcome was time to surgery (TTS) in hours. Secondary outcomes include inpatient transfusion and thromboembolism rates and 30-day mortality.

Results: 1579 patients underwent operative management of their hip fracture. The mean TTS in the DOAC group was 33.0 hours. This was significantly longer when compared to patients not on anticoagulation whose mean TTS was 24.4hours (95% CI -13.78: -8.71, P value <.05). It was also significantly higher than patients on warfarin whose mean TTS was 26.4hours (95% CI -12.41: -4.18, P value <.05). There was no significant difference in the transfusion rate and 30-day mortality between the groups (X2 = 2.086, df = 2, P value = .352)]. There was no significant difference in transfusion rates and 30-day mortality between the patients with a DOAC level <50 ng/mL compared with the patients not on any anticoagulation. There was no significant difference in 30-day mortality or transfusion rates between those patients on a DOAC operated within 48 hours compared with those operated after 48 hours (P value = .67).

Discussion and conclusion: DOAC therapy delays surgery for patients with a hip fracture. Using a DOAC level <50 ng/mL is a safe level to proceed with surgery and reduces the TTS compared to following current guidelines. If DOAC levels are not available the data still supports operation at 48 hours.

术前直接口服抗凝血水平测量减少髋部骨折患者手术时间。
在围手术期创伤患者服用DOAC药物的最佳管理是基于有限的证据。目前的指南建议术前48-72小时停用DOAC药物。本试验的目的是确定在手术前测量DOAC水平的效用,评估材料和方法的截止水平的安全性:我们对2017年1月12日至2019年12月31日期间接受手术的50岁及以上髋部骨折患者进行了队列研究。主要观察指标为手术时间(TTS),单位为小时。次要结局包括住院输血和血栓栓塞率以及30天死亡率。结果:1579例患者行髋部骨折手术治疗。DOAC组平均TTS为33.0小时。与未使用抗凝治疗的患者相比,TTS的平均时间为24.4小时(95% CI -13.78: -8.71, P值P值2 = 2.086,df = 2, P值= 0.352)。DOAC水平患者之间输血率和30天死亡率无显著差异(P值= 0.67)。讨论与结论:DOAC治疗延迟了髋部骨折患者的手术时间。使用DOAC级别
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.00
自引率
0.00%
发文量
80
审稿时长
9 weeks
期刊介绍: Geriatric Orthopaedic Surgery & Rehabilitation (GOS) is an open access, peer-reviewed journal that provides clinical information concerning musculoskeletal conditions affecting the aging population. GOS focuses on care of geriatric orthopaedic patients and their subsequent rehabilitation. This journal is a member of the Committee on Publication Ethics (COPE).
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信